ASAP News

More heroin users are inhaling the drug and it’s causing them irreversible brain damage and dementia, according to a recent report published in JAMA Neurology. Heating heroin and inhaling it (referred to in the report as “Chasing the Dragon”) worries […]

By the end of this year, more than three dozen communities across the country will have begun participation in a national initiative designed to bring together a diversity of stakeholders to solve local problems related to addiction. Facing Addiction with

More U.S. workers tested positive for cocaine and methamphetamine in 2017, according to numbers from Quest Diagnostics. The company analyzed more than 10 million drug tests. The increase was especially evident in certain parts of the nation. In a few Southern states – Alabama,

In spring 2018, Congress added an additional $500 million to the NIH budget to invest in science to find solutions to the opioid crisis. The Helping to End Addiction Long-term (HEAL) initiative is being kicked off today with the announcement

More people now die from overdosing on synthetic opioids – mainly fentanyl – than prescription painkillers, according to a recent study. The number of deaths due to synthetic opioids surpassed 19,000 in 2016. The drugs were involved in more than 30

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that lofexidine, the first medication for use in reducing symptoms associated with opioid withdrawal in adults, has been approved by the U.S.

The opioid crisis is real, growing and heartbreaking. A third of Americans have been prescribed opioid painkillers, and opioids are so addictive that research suggests 1 in 5 who start a 10-day supply become longer-term users. As a leading writer

ASAP is going to New Orleans and will be at Booth 602, so stop by and visit! Join your colleagues and industry experts for the industry’s premier educational event. With Over 800 attendees, 85 exhibitors, 25 educational sessions, and pre-

A provision of Maine’s recreational marijuana law prohibits employers from taking adverse employment actions for off-premises marijuana use, as of February 1, 2018. This law effectively prevents Maine employers from testing for marijuana for pre-employment purposes.  The law also affects

One of the pillars of the current federal initiatives to end the opioid crisis is the development of new medications to treat opioid addiction. Currently we have three approved drugs—methadone, buprenorphine, and naltrexone—in a growing number of formulations, including some